This page gives details of CPPsite entry with ID 2532 |
| Primary information | |
|---|---|
| CPPsite ID | 2532 |
| PEPTIDE SEQUENCE | RRRRRR |
| PEPTIDE NAME | V2 |
| CHIRALITY | L |
| LINEAR/CYCLIC | Linear |
| SOURCE | Synthetic |
| CATEGORY | Cationic |
| SUB CELLULAR LOCALIZATION | Cytoplasm and Nucleus |
| N-TERMINAL MODIFICATION | Conjugated to FITC modified folding domain via β-alanine–glycine– glycine linker |
| C-TERMINAL MODIFICATION | Amidation |
| UPTAKE EFFICIENCY | V2 has a stronger preference to accumulate within the nuclear bodies that contain a high con- centration of DNA |
| INVITRO/INVIVO | In vitro |
| CELL LINE | NIH-3T3 Swiss mice fibroblasts and Jurkat E6 cells |
| CARGO | Peptide (FITC labelled peptide) |
| PMID | 25524829 |
| PATENT | Unknown |
| LENGTH | 6 |
| Secondary Structure | CCCCCC |
| SMILES | N[C@@H](CCCNC(=[NH2])N)C(=O)N[C@@H](CCCNC(=[NH2])N)C(=O)N[C@@H](CCCNC(=[NH2])N)C(=O)N[C@@H](CCCNC(=[NH2])N)C(=O)N[C@@H](CCCNC(=[NH2])N)C(=O)N[C@@H](CCCNC(=[NH2])N)C=O |
| Tertiary Structure (Technique) | View in Jmol  OR Download Structure (PEPstrMOD) |